The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTAExternal) have established a joint three-year work plan, identifying the following key areas of collaboration: scientific advice/early dialogue with sponsors, scientific and methodological guidelines development, post-authorisation data generation and orphan medicinal products. More information is available on the EMA website